Skip to main content
OpenTrials

Clinical trial condition

Refractory Childhood Malignant Solid Neoplasm

Explore clinical trials studying Refractory Childhood Malignant Solid Neoplasm. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Refractory Childhood Malignant Solid Neoplasm trial results

Recruiting

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

NCT06620302

Conditions
Childhood Fibrolamellar Carcinoma, Fibrolamellar hepatocellular carcinoma, Recurrent Childhood Fibrolamellar Carcinoma, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 21 locations
View Trial Details

Related conditions